 | Info Sheets |
| | | | | | | | | | | | | | | | | | | | | | | | |
 | Out- side |
| | | | |
|
| | | | | |  | Searchterm 'Bo' was also found in the following services: | | | | |
|  |  |
| |
|

From Siemens Medical Systems;
Received FDA clearance in 2007.
The MAGNETOM Verio provides up to 102 integrated matrix coil elements and up to 32 independent radiofrequency channels that allow flexible coil combinations to make patient and coil repositioning virtually unnecessary. The Tim (total imaging matrix) technology also increases patient throughput due to a shorter scan time.
The open bore design offers great comfort for patients of all shapes and sizes.
Device Information and Specification
CLINICAL APPLICATION
Whole Body
CONFIGURATION
Ultra-short open bore
Head, spine, torso/ body coil, neurovascular, cardiac, neck and multi-purpose flex coils. Peripheral vascular, breast, shoulder, knee, wrist, foot//ankle, TMJ optional.
CHANNELS (min. / max. configuration)
8, 18, 32
Chemical shift imaging, single voxel spectroscopy
MAGNET WEIGHT (gantry included)
8200 kg
DIMENSION H*W*D (gantry included)
173 x 230 x 222 cm
Passive, active; first order,
second order standard
POWER REQUIREMENTS
380 / 400 / 420 / 440 / 460 / 480 V, 3-phase + ground; 110 kVA
| |  | | | |
|  | |  |  |  |
| |
|

From Siemens Medical Systems;
70 cm + 125 cm + 1.5T and Tim - a combination never seen before in MRI ...
MAGNETOM Espreeâ„¢s unique open bore design can accommodate more types of patients than other 1.5T systems on the market today, in particular the growing population of obese patients. The power of 1.5T combined with Tim technology boosts signal to noise, which is necessary to adequately image obese patients.
Device Information and Specification
CLINICAL APPLICATION
Whole body
Body, Tim [32 x 8], Tim [76 coil elements with up to 18 RF channels])
GRE, IR, FIR, STIR, TrueIR/FISP, FSE, FLAIR, MT, SS-FSE, MT-SE, MTC, MSE, EPI, 3D DESS//CISS/PSIF, GMR
IMAGING MODES
Single, multislice, volume study, multi angle, multi oblique
Image Processor reconstructing up to 3226 images per second (256 x 256, 25% recFoV)
1024 x 1024 full screen display
| |  | | • View the DATABASE results for 'MAGNETOM Espree™' (2).
| | | | Further Reading: | News & More:
|
|
| |
|  | |  |  |  |
| |
|
Resovist® is an organ-specific MRI contrast agent, used for the detection and characterization of especially small focal liver lesions.
Resovist® consists of superparamagnetic iron oxide ( SPIO) nanoparticles coated with car boxydextran, which are accumulated by phagocytosis in cells of the reticuloendothelial system (RES) of the liver. The uptake of Resovist® Injection in the reticuloendothelial cells results in a decrease of the signal intensity of normal liver parenchyma on both T2- and T1 weighted images.
Most malignant liver tumors do not contain RES cells and therefore do not uptake the iron particles. The resulting imaging effect is an improved contrast between the tumor (bright) and the surrounding tissue (dark).
Resovist® can be injected as an intravenous bolus, which allows immediate imaging of the liver and reduces the overall examination time. A dynamic imaging strategy after bolus injection supports to characterize lesions.
In comprehensive clinical trials, it demonstrated an excellent safety profile.
In 2001, Resovist® was approved for the European market.
See also Superparamagnetic Iron Oxide.
Resovist® competed with Primovist™, the other liver imaging agent of Bayer Schering Pharma AG. Due to this reason, the production of Resovist® has been abandoned in 2009.
Drug Information and Specification T2/T1, Predominantly negative enhancement PHARMACOKINETIC RES-directed CONCENTRATION 0.5 mol Fe/L DOSAGE Less than 60 kg = 0.9 ml, greater than 60 kg = 1.4 ml PREPARATION Finished product PRESENTATION
Pre-filled syringes of 0.9 and 1.4 mL DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT!
Distribution Information TERRITORY TRADE NAME DEVELOPMENT STAGE DISTRIBUTOR Japan Resovist® approved - Australia Resovist® Approved - | |  | | • View the DATABASE results for 'Resovist®' (6).
| | | | Further Reading: | News & More:
|
|
| |
|  |  | Searchterm 'Bo' was also found in the following services: | | | | |
|  |  |
| |
|
Device Information and Specification CLINICAL APPLICATION Whole body Head and body coil standard; all other coils optional; open architecture makes system compatible with a wide selection of coils Standard: SE, IR, 2D/3D GRE and SPGR, Angiography;; 2D/3D TOF, 2D/3D Phase Contrast;; 2D/3D FSE, 2D/3D FGRE and FSPGR, SSFP, FLAIR, optional: EPI, 2D/3D Fiesta, FGRET, SpiralTR 4.4 msec to 12000 msec in increments of 1 msec TE 1.0 to 2000 msec; increments of 1 msec Simultaneous scan and reconstruction;; up to 100 images/second with Reflex 100 2D 0.7 mm to 20 mm; 3D 0.1 mm to 5 mm 128x512 steps 32 phase encode 0.08 mm; 0.02 mm optional POWER REQUIREMENTS 480 or 380/415 V Less than 0.03 L/hr liquid heliumSTRENGTH SmartSpeed 23 mT/m, HiSpeed Plus 33 mT/m 4.0 m x 2.8 m axial x radial | |  | | • View the DATABASE results for 'Signa Infinity 1.0T™' (2).
| | | | |
|  | |  |  |  |
| |
|

From GE Healthcare;
three dedicated MRI systems - a neuro imager, a cardiovascular system, and a whole body scanner - all in one system.
Device Information and Specification CLINICAL APPLICATION Whole body Head and body coil standard; all other coils optional; open architecture makes system compatible with a wide selection of coils Optional 2D/3D brain and prostate Standard: SE, IR, 2D/3D GRE and SPGR, Angiography: 2D/3D TOF, 2D/3D Phase Contrast;; 2D/3D FSE, 2D/3D FGRE and FSPGR, SSFP, FLAIR, EPI, optional: 2D/3D Fiesta, FGRET, Spiral, TensorTR 1.2 to 12000 msec in increments of 1 msec TE 0.4 to 2000 msec in increments of 1 msec 2D 0.7 mm to 20 mm; 3D 0.1 mm to 5 mm 128x512 steps 32 phase encode POWER REQUIREMENTS 480 or 380/415 Less than 0.03 L/hr liquid He STRENGTH Zoom 40 mT/m, whole body 23 mT/m 4.0 m x 2.8 m axial x radial | |  | | • View the DATABASE results for 'Signa Infinity 1.5T™ TwinSpeed with Excite' (2).
| | | | Further Reading: | News & More:
|
|
| |
|  | |  |  |
|  |
|  | | |
|
| |
 | Look Ups |
| |